| ID | 1692 |
|---|
| No | 1692 |
|---|
| Brand Name | LUCIBET |
|---|
| Ingredients | BICTEGRAVIR SODIUM 50 MG, EMTRICITABINE 200 MG, TENOFOVIR ALAFENAMIDE 25 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 30'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | AS A COMPLETE REGIMEN FOR THE TREATMENTOF HIV-1 INFECTION IN ADULT AND PEDIATRIC PATIENTS WIEGHING AT LEAST 14 KG |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | DARK RED COLORED, ROUND TABLETS, LETTER LUCIUS ON ONE SIDE AND PLAIN ON THE OTHER |
|---|
| Note | |
|---|
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 01 L 1291/25 |
|---|
| FDD Registration Date | 03/02/2025 |
|---|
| Expiry Date | 02/02/2030 |
|---|
